Carol Talkington-Verser

Title: Carol Talkington-Verser: Innovator in Therapeutic Applications

Introduction

Carol Talkington-Verser is a notable inventor based in San Rafael, California. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic applications involving human somatomedin carrier proteins. With a total of four patents to her name, her work has the potential to impact various medical and diagnostic fields.

Latest Patents

One of her latest patents focuses on the therapeutic uses of human somatomedin carrier proteins. This invention relates to polypeptides that are human somatomedin carrier protein subunits and to processes for producing them. The carrier protein subunits bind to human somatomedin-like polypeptides, also known as insulin-like growth factors. The process involves preparation from a human serum fraction, Cohn IV-1, through various chromatographic steps. Additionally, this invention encompasses DNA molecules encoding human somatomedin carrier protein-like polypeptides, recombinant DNA molecules, hosts, and processes for producing these carrier protein-like polypeptides. The invention also includes methods for producing complexes of human somatomedin carrier protein-like polypeptides and somatomedins, utilizing recombinant technology.

Career Highlights

Carol Talkington-Verser is currently associated with Celtrix Pharmaceuticals, Inc., where she continues to innovate in the field of biotechnology. Her work has been instrumental in advancing the understanding and application of human somatomedin carrier proteins in therapeutic contexts.

Collaborations

One of her notable coworkers is Emerald Martin Spencer, who also contributes to the innovative efforts at Celtrix Pharmaceuticals, Inc.

Conclusion

Carol Talkington-Verser exemplifies the spirit of innovation in biotechnology through her patents and contributions to therapeutic applications. Her work continues to pave the way for advancements in medical science.